SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network is trending due to a recent AI-related partnership and exceptionally high short interest, sparking intense speculation among traders. The community is actively debating the potential for a substantial short squeeze, drawing comparisons to historical parabolic runs, as investors weigh the dramatic upward momentum against the risks of a significant pullback.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to reports of a substantial government investment, acquiring an equity stake and providing significant financing to bolster domestic critical mineral production for national security. This development has sparked highly bullish sentiment among the community, with many anticipating substantial price gains and a short squeeze, while also prompting discussions around valuation and market influences within the rare earth sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is experiencing a dramatic rally, with community chatter centered on a significant short squeeze and a re-evaluation of silver as a hard asset amid concerns about currency devaluation and economic stability. Euphoric bulls are pushing for higher prices, citing industrial demand and historical suppression, while bears anticipate an imminent "blow off top" and a sharp correction as profit-taking looms.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold prices reach unprecedented levels, with community discussion centered on its role as a premier safe haven asset amid heightened global geopolitical tensions and concerns over currency stability. Many investors are celebrating significant gains and anticipating further upside, while some caution about an overextended market and the potential for a sharp correction. This rally is widely perceived as a flight to quality, driven by central bank diversification and a diminishing trust in traditional financial assets.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune (ALT) is currently trending as community optimism grows following its Breakthrough Therapy Designation for MASH, positioning its drug, Pemvidutide, as a de-risked and highly attractive asset. Discussions are heating up around a potential partnership or major buyout, driven by Pemvidutide's 'best-in-class' profile in the burgeoning MASH and obesity markets, amidst notable trading volume and short squeeze speculation.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following its U.S. subsidiary's submission of a consolidated deep-seabed mining application to NOAA, a move that significantly expands its potential recovery area and streamlines the permitting process. This development, coupled with broader U.S. government focus on securing critical mineral supply chains, has ignited extremely bullish sentiment within the community. Investors are actively discussing the likelihood of swift permit approval and anticipating substantial upside driven by national security implications and the urgency to reduce reliance on foreign mineral sources.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp (UAMY) is trending following its acquisition of a critical minerals flotation facility, strategically enhancing its ability to process antimony and other valuable materials. The community is highly bullish, anticipating significant government investment, especially given the company's existing role as a sole-source antimony supplier for the US military. Investors see UAMY as a prime play in the critical minerals sector, comparing its potential to other recently-backed miners in a climate of increased demand.

Skywater Technology, Inc. is a holding company. It engages in the provision of semiconductor development, manufacturing services, and packaging services. The company was founded on October 3, 2016 and is headquartered in Bloomington, MN.

SkyWater Technology Inc

SkyWater Technology is a major talking point following strong earnings and an optimistic long-term revenue outlook, which has been reinforced by a recent analyst upgrade. The community is abuzz with its strategic importance as a domestic foundry, focusing on quantum computing, aerospace, defense, and advanced packaging amid U.S. chip reshoring efforts. Investors are actively debating the company's significant growth potential, with many viewing recent price dips as prime opportunities.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is captivating the community following remarkable survival data from its glioblastoma trial and significant international approvals for its Anktiva immunotherapy in lung and bladder cancers. Investors are eagerly discussing the company's expansive "BioShield" platform and the potential for a substantial short squeeze, driven by considerable short interest and upcoming catalysts for its multi-organ HPV vaccine. This convergence of positive developments positions IBRX as a key player disrupting the oncology landscape with chemo-free solutions.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is drawing significant attention ahead of its anticipated earnings report, with community discussion sharply divided between long-term bullish sentiment fueled by institutional accumulation and the potential for S&P 500 inclusion, and intense frustration over persistent price stagnation and perceived market manipulation. Many investors are buying recent dips, anticipating a breakout, despite ongoing concerns about dilution and broader fintech sector pressures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Massachusetts Financial Services Co. MA Sells 165,185 Shares of Globus Medical, Inc. $GMED

Massachusetts Financial Services Co. MA lowered its stake in Globus Medical, Inc. (NYSE:GMED - Free Report) by 19.5% in the 3rd quarter, according to the company in its most recent Form 13F filing...

Globus Medical, Inc. (NYSE:GMED) Given Average Recommendation of "Moderate Buy" by Brokerages

Globus Medical, Inc. (NYSE:GMED - Get Free Report) has earned an average recommendation of "Moderate Buy" from the fifteen analysts that are currently covering the firm, MarketBeat Ratings reports...

Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Anchor Capital Advisors LLC Purchases 237,331 Shares of Globus Medical, Inc. $GMED

Anchor Capital Advisors LLC raised its position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 42.2% in the 3rd quarter, according to the company in its most recent Form 13F filing...

Should You Still Hold GMED Stock in Your Portfolio?

Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.

Stephens Investment Management Group LLC Increases Stock Position in Globus Medical, Inc. $GMED

Stephens Investment Management Group LLC boosted its holdings in Globus Medical, Inc. (NYSE:GMED - Free Report) by 10.7% in the 3rd quarter, according to the company in its most recent 13F filing...

Pembroke Management LTD Sells 38,745 Shares of Globus Medical, Inc. $GMED

Pembroke Management LTD lowered its position in Globus Medical, Inc. (NYSE:GMED - Free Report) by 6.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

Insider Move: Kyle Kline Exercises Options, Realizing $125K At Globus Medical

Kyle Kline Sells 3,594 Shares of Globus Medical (NYSE:GMED) Stock

Globus Medical, Inc. (NYSE:GMED - Get Free Report) CFO Kyle Kline sold 3,594 shares of the firm's stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of...

Globus Medical (NYSE:GMED) CFO Kyle Kline Sells 3,594 Shares

Globus Medical, Inc. (NYSE:GMED - Get Free Report) CFO Kyle Kline sold 3,594 shares of the firm's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Globus Medical Inc - Ordinary Shares - Class A

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

GMED
Globus Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GMED News

GMEDGlobus Medical Inc